CMR validation of fractional changes in annulo-apical angles and TAPSE for rapid assessment of right ventricular systolic function
© Zakeri et al; licensee BioMed Central Ltd. 2012
Published: 1 February 2012
Volumetric assessment of the right ventricle (RV) by Cardiac Magnetic Resonance (CMR), albeit time-consuming, provides accurate and reproducible measurement of RV ejection fraction (RVEF). Tricuspid annulus peak systolic excursion (TAPSE) is a predominantly Echo-validated rapidly-derived surrogate of RV function. Correlations between RVEF and systolic changes in annulo-apical angles (AAAs) have not previously been evaluated.
To assess the use of changes in AAAs and TAPSE as rapidly-derived surrogate markers of RV systolic function using CMR.
Forty subjects were included: 10 normals, 10 mildly-impaired, 10 moderately-impaired, and 10 with severely-impaired RV systolic function. Median (25th-75th percentile) RVEF for each subgroup was 53.5% (51.4%-55.7%), 41.5% (38.1%-47.2%), 30.0% (21.7%-33.5%), and 15.8% (9.6%-21.2%), respectively. Correlations with RVEF: TAPSE (0.74 p<0.001), fractional changes of α angle (0.64, p<0.001), β angle (-0.39, p<0.05), and θ angle, which had the highest correlation (-0.77, p<0.001). Smaller increases or a decrease in magnitude of the θ angle from ED to ES are associated with lower RVEFs, whereby a fractional θ angle change of ≥ -25.5% predicts RVEF<50% [97% sensitivity, 91% specificity, AUC=0.98]. The cut-off for TAPSE is ≤1.87cm [100% sensitivity, 82% specificity, AUC=0.98]. Intra- and inter-observer reproducibility is excellent as shown by intra-class correlation coefficients for TAPSE (0.98 and 0.92, respectively) and fractional θ angle change (0.96 and 0.80, respectively).
Both fractional θ angle change and TAPSE strongly correlate with RVEF, and are accurate predictors of RVEF<50%. These measurements provide an excellent alternative to the more time-consuming derivation of RVEF obtained volumetrically by endocardial chamber tracing.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.